Interleukin-6 and insulin-like growth factor-1 synergistically promote the progression of NSCLC

• Main Authors: Hexiao Tang (Author), Yuquan Bai (Author), Gaofeng Pan (Author), Xianguo Wang (Author), Yanhong Wei (Author), Zetian Yang (Author), Jinping Zhao (Author)
• Format: Book
• Published: Taylor & Francis Group, 2018-11-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

The signaling pathways of interleukin-6 (IL-6) and insulin-like growth factor 1 (IGF-1) play an important role in the progression of lung cancer, and this study aimed to explore whether they can synergistically promote the progression of non-small cell lung cancer (NSCLC). We found that IL-6, glycop...